Solventum Analyst Ratings
Goldman Sachs Adjusts Price Target on Solventum to $48 From $54
Solventum Analyst Ratings
B of A Securities Maintains Neutral on Solventum, Lowers Price Target to $60
Solventum Analyst Ratings
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target
Solventum Analyst Ratings
Maintaining Hold on Solventum: A Cautious Outlook on Long-Term Turnaround and Growth Prospects
Analysts' Opinions Are Mixed on These NA Stocks: Boundless Bio Inc. (BOLD) and Solventum Corporation (SOLV)
Maintaining Hold on Solventum Corp Amidst Conservative Growth Projections and Ongoing Litigation Uncertainty
Solventum Analyst Ratings
Solventum Analyst Ratings
RBC Cuts Price Target on 3M to $78 From $84 to Reflect Spinoff of Solventum, Keeps Underperform Rating
Solventum Analyst Ratings